Company / Shares Outstanding
Exelixis Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
281.7M
FY2025
5-year range
281.7M / 324.0M
FY2021-FY2025
Trend
-7.0%
vs FY2024
Sector context
#33 of 212
Health Care
What the data says
Exelixis's shares outstanding of 281732000.00 is higher than 84% of companies in the Health Care sector (FY2025). Improved from 323951000.00 to 281732000.00 over the past 2 years.
Based on SEC 10-K filings.
281732000.00 in FY2025 with a 5-year CAGR of -1.6%. Top quartile in the Health Care sector.
Improved from 323951000.00 to 281732000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -4.0%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 212This company 281.7M Sector average 306.0M
▼
-7.9% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 7.0% year-over-year.
- Ranks #33 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2023.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 281.7M | -7.0% |
| FY2024 | 302.8M | -6.5% |
| FY2023 | 324.0M | +1.6% |
| FY2022 | 318.8M | +2.3% |
| FY2021 | 311.6M | +2.2% |
| FY2020 | 304.8M | +1.7% |
| FY2019 | 299.9M | +1.2% |
| FY2018 | 296.2M | +2.2% |
| FY2017 | 289.9M | +27.2% |
| FY2016 | 228.0M | +16.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026